Search

everythinglearnresearchcommunity

for

Search:↓

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Adding a second method to PROTACs could improve cancer treatment.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Scientists made antibodies to tell cashmere and wool apart, which could improve how we identify animal fibers.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Cepharanthine shows promise as a COVID-19 treatment.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Cepharanthine shows promise as a natural anticancer treatment.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Gene expression in milk cells and blood can help detect illegal rbST use in cows.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Icariside II may help treat gastric cancer by stopping tumor growth.